• This new healthcare-focused delivery marks the continued acceleration of FF EAI robot sales and deployment, giving the Company greater confidence in achieving its shipment targets of 200 units in the first delivery season and 1,500 units for the full year.

Faraday Future Intelligent Electric Inc. (Nasdaq: FFAI) (“Faraday Future,” “FF,” or the “Company”), a California-based global Embodied AI (EAI) ecosystem company, today announced the delivery of its Master™ humanoid (robot) to a well-known medical institution in Los Angeles, the first real-world implementation of FF’s EAI robots in a healthcare use case. The delivery, made to Wonderful Life Dental Group Los Angeles, will be primarily used to support their front-desk functions in a healthcare scenario, including patient check-in, appointment look-up, reception assistance, and wayfinding guidance. For now, it will deliberately avoid any clinical/medical procedure areas.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260604499405/en/

Faraday Future Completes Delivery of EAI Robot FF Master to Wonderful Life Dental Group Los Angeles, the First Real-World Implementation of FF’s EAI Robots in a Healthcare Use Case

This healthcare delivery milestone for FF marks a significant step toward becoming the first company in the U.S. market to achieve deliveries of EAI robots in many different use-case scenarios including healthcare, education, performance and hospitality settings. Healthcare environments are a great fit for this robot function since Master™ can communicate in more than 50 languages; it can better serve a diverse patient population and help improve accessibility across different language backgrounds.

A video of the Dental Group delivery and patient interaction can be accessed here: https://youtu.be/puXrLHOXDCg

“I just wanted the newest technology in the office, and I think FF EAI robotics is the trend to go with. I wanted to eliminate inefficiencies in the office, and have it help guide patients,” said Dr. Jack Y. Pai, Owner, Wonderful Life Dental Group. “I would definitely recommend Master™ (robot) to all practices; it’s not just a robot, it’s a smart assistant that helps the staff, it’s a great way for them to interact with patients, and a great way to help operational flow and make sure everything goes smoothly.”

This delivery marks the continued acceleration of FF EAI robot sales and deployment, giving the Company greater confidence in achieving its shipment targets of 200 units in the first delivery season and 1,500 units for the full year. More importantly, it shows that FF’s multi-form EAI robot device roadmap is beginning to show early results. FF continues delivering EAI robots in multiple forms, including both humanoid and bionic robots, and addressing real-world needs in education, security and inspection, reception and guidance, healthcare, and other use cases; FF aims to match the right device form with the right use case.

Those interested in learning more about FF EAI Robotics or making an order can access more information here: https://g.ff.com/OrderFFRobots

ABOUT FARADAY FUTURE

Founded in 2014, Faraday Future (FF) is a U.S.-based Physical AI ecosystem company dedicated to reshaping the future of robotics and mobility solutions through AI innovation and technologies. FF focuses on two major product strategies within the Embodied AI (EAI) robotics business: EAI humanoid and bionic robots, and EAI automotive-focused robots. By building a Three-in-One ecosystem of “Device, Data, EAI Brain & Open-Source and Open Platform,” FF aims to create an evolutionary flywheel: scaled device delivery, data collection and training, continuous evolution of the EAI Brain, stronger product capability, and even larger-scale delivery and deployment. Through this flywheel, FF seeks to maximize its commercial value and lead to the advancement of Physical AI. For more information, please visit Faraday Future’s official website: https://www.ff.com/

FORWARD LOOKING STATEMENTS

This press release includes “forward looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words “plan to,” “can,” “will,” “should,” “future,” “potential,” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements, which include statements regarding potential future legal actions against alleged illegal market manipulation or similar improper activities, and FF’s entry into the embodied AI robotics market and robotics deliveries and development, involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company’s control, which could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements.

Important factors, that may affect actual results or outcomes include, among others: the Company’s ability to timely regain compliance with Nasdaq’s minimum bid requirement; the Company’s common stock will be suspended from trading on Nasdaq if its closing price is $0.10 or less for 10 consecutive trading days; the Company’s ability to continue as a going concern and improve its liquidity and financial position; the Company’s ability to pay its outstanding obligations, which it currently lacks; the availability of sufficient share capital to meet its current obligations and execute on its strategy, which the Company currently lacks; the agreement of stockholders to substantially increase the Company’s share capital, which could result in substantial additional dilution; the willingness of convertible debt investors to fund the Company while it lacks sufficient share capital for conversions; demand for the Company’s robotics products; the ability of B2B preorder companies to locate customers to purchase our robotics products, on which their nonbinding preorders substantially depend; competition in the robotics industry, which includes companies with far superior experience, funding and name recognition; the Company’s reliance on a single OEM for most of its robotics products; the Company’s ability to get the planned robotics products to comply with all applicable U.S. rules and regulations; the ability of the robotics OEM to timely supply robotics to the Company; tariff uncertainty for imported products, particularly from China; demand from automobile dealers for robotics products; the Company's ability to homologate FX vehicles for sale; the Company’s ability to secure the necessary funding to execute on the FX strategy, which is substantial; the Company’s ability to secure an occupancy certificate covering all of its Hanford facility; the Company's ability to remediate its material weaknesses in internal control over financial reporting and the risks related to the restatement of previously issued consolidated financial statements; the Company’s limited operating history and the significant barriers to growth it faces; the Company’s history of substantial losses and expectation of continued losses; the success of the Company’s payroll expense reduction plan; the Company’s ability to execute on its plans to develop and market its vehicles and the timing of these development programs; the Company’s estimates of the size of the markets for its vehicles and cost to bring those vehicles to market; the rate and degree of market acceptance of the Company’s vehicles; the Company’s ability to cover future warranty claims; the success of other competing manufacturers; the performance and security of the Company’s vehicles; current and potential litigation involving the Company; the Company’s ability to receive funds from, satisfy the conditions precedent of and close on the various financings described elsewhere by the Company; the result of future financing efforts, the failure of any of which could result in the Company seeking protection under the Bankruptcy Code; the Company’s indebtedness; the Company’s ability to use its “at-the-market” program; insurance coverage; general economic and market conditions impacting demand for the Company’s products; potential negative impacts of a reverse stock split; potential cost, headcount and salary reduction actions may not be sufficient or may not achieve their expected results; circumstances outside of the Company's control, such as natural disasters, climate change, health epidemics and pandemics, terrorist attacks, and civil unrest; risks related to the Company's operations in China; the success of the Company's remedial measures taken in response to the Special Committee findings; the Company’s dependence on its suppliers and contract manufacturer; the Company's ability to develop and protect its technologies; the Company's ability to protect against cybersecurity risks; and the ability of the Company to attract and retain employees, any adverse developments in existing legal proceedings or the initiation of new legal proceedings, and volatility of the Company’s stock price. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of the Company’s Form 10-Q for the quarter ended March 31, 2026, filed with the SEC on May 14, 2026, and Form 10-K filed with the SEC on March 31, 2026, and other documents filed by the Company from time to time with the SEC.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260604499405/en/